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Assembly of virus capsids and surface proteins must be regulated to ensure that the 1 
resulting complex is an infectious virion. Here we examine assembly of virus capsids, 2 
focusing on hepatitis B virus and bacteriophage MS2, and formation of glycoproteins in 3 
the alphaviruses. These systems are structurally and biochemically well-characterized 4 
and are simplest-case paradigms of self-assembly. Published data suggest that capsid 5 
and glycoprotein assembly is subject to allosteric regulation, that is, regulation at the 6 
level of conformational change. The hypothesis that allostery is a common theme in 7 
viruses suggests that deregulation of capsid and glycoprotein assembly by small 8 
molecule effectors will be an attractive antiviral strategy, as has been demonstrated with 9 
hepatitis B virus. 10 
 11 
Is regulation of self-assembly required? 12 
The common structural denominator for a typical small virus is a genome surrounded by a shell 13 
composed of dozens of copies of the capsid protein. Many small viruses also have lipid 14 
envelopes studded with glycoproteins that can facilitate cell entry. Even a small virus is 15 
complex, yet its formation is a canonical example of self-assembly.  Given the right conditions, 16 
the capsid proteins of many viruses will assemble to capsid-like structures, rapidly, in high yield, 17 
and with high fidelity (Table 1). This observation opens up two distinct fields of study: the 18 
process of self-assembly and regulation of assembly. The process of self-assembly is best 19 
described by physical chemistry; for example, self-assembly can be modeled by a system of 20 
differential equations or emulated with small molecules.  Regulating assembly, on the other 21 
hand, is fundamentally biochemical and ultimately biological in nature. Consider our hypothetical 22 
virus where unregulated assembly would yield capsids that did not contain the viral genome and 23 
toxic accumulation of fusion protein. These spontaneous assembly reactions must be delayed 24 
until the right time and place. Regulation is likely to be at the level of allostery, which is defined 25 
as a conformational change in a molecule, usually a protein, that alters its activity, induced by 26 
an effector molecule. In addition to allostery, regulation could require viral or host factors. 27 
Regulation of the large event of virus assembly by a small reaction, such as inducing 28 
conformational change of a single protein, provides the leverage that allows virus replication in 29 
vivo. Disruption of regulation is an ideal target for antiviral therapeutics. Defining the regulation 30 
that directly controls the physical chemistry of assembly is a field in its infancy and the focus of 31 
this review. 32 
In this review, we will separately examine the assembly of virus capsids and the membrane-33 
bound glycoprotein complexes present on the exterior of enveloped viruses. Both the capsid 34 
and glycoprotein are protein oligomers; from a physical-chemical perspective, their assembly is 35 
similar; from a biological perspective they demonstrably have similar elements of regulation. 36 
Though there are numerous experimental systems (Tables 1 and 2), the discussion of capsid 37 
assembly will focus on hepatitis B virus (HBV) with significant references to retroviruses and 38 
bacteriophage MS2. Furthermore, small molecules that dramatically affect HBV assembly have 39 
demonstrable antiviral activity. The discussion on glycoprotein assembly will focus on the 40 
formation of the spike complex of alphaviruses as the spike is composed of two proteins which 41 
intricately interact and are required for viral entry.  Finally, we will discuss potential steps in 42 
assembly that could be targeted for designing antiviral therapeutics.   43 
 44 
Assembly of virus capsids 45 
The capsids of icosahedral viruses have tens to hundreds of copies of the capsid protein(s).  46 
The simplest vision of virus capsid assembly is one where rigid assembly units (AUs) collide by 47 
 3 
Brownian motion, interact with perfect geometry, and associate irreversibly. Like any utopia, this 1 
vision fails examination: assembly simulations are incredibly sensitive to kinetic traps consisting 2 
of partial capsids that have a negligible chance of completion due to depletion of subunits 3 
(Figure 1).  4 
Instead, assembly simulations, from master equations that treat assembly reactions as a well-5 
mixed solution2, 3 to molecular dynamics that describe stochastic formation of single capsids4, 5, 6 
concur on three generalizations (Box 1). First, weak interactions are necessary to minimize 7 
errors and kinetic traps. Weak interactions also contribute to a defined nucleation step. Second, 8 
nucleation minimizes the initiation of assembly, decreasing kinetic trapping of intermediates due 9 
to depletion of AUs. Third, the initial kinetic phase where there is little capsid formation is due to 10 
the time required to build the steady state of intermediates that supports subsequent assembly. 11 
More sophisticated mathematical models that incorporate the biological details of individual 12 
viruses (e.g. nucleic acid, scaffolding, and allostery) will help to identify opportunities to interfere 13 
with assembly. 14 
Experimental observation of assembly of empty HBV capsids agrees well with the predictions of 15 
theoretical models6 (Box 1). HBV has a T=4 icosahedral capsid composed of 120 assembly 16 
units, the homodimeric core protein (Cp)7. Cp can be assembled in vitro in response to ionic 17 
strength6 and the kinetics are sigmoidal6. The average association energy between two subunits 18 
is -3 to -4 kcal/mol, corresponding to a millimolar dissociation constant.  Because subunits are 19 
tetravalent, the weak association energy corresponds to a micromolar pseudo-critical 20 
concentration8. In vitro HBV assembly is resistant to, but not altogether immune to, kinetic 21 
traps9, 10.  22 
HBV is a simplest case system, a homopolymer of dimeric AUs. In cowpea chlorotic mottle virus 23 
and bacteriophage HK97, different complexes of AUs participate in assembly11, 12. In many 24 
viruses, scaffold proteins support assembly. Bacteriophage P22 has a scaffold protein that 25 
thermodynamically and kinetically contributes to assembly13, 14. Excess P22 scaffold can 26 
actually block assembly by trapping numerous intermediates14. Scaffolds can play roles in 27 
switching morphologies, as in bacteriophages P2 and P415, and complex roles in subsequent 28 
maturation16. Thus, scaffold proteins could direct geometry, stability, and a measure of 29 
regulation by imposing stepwise assembly. 30 
Viral nucleic acid can also serve as a molecular scaffold. Viral RNA has been considered as an 31 
‘antenna’ to attract free AUs17 and as a solid that attracts and organizes AUs on its surface18. 32 
Assembly driven by RNA can be thought of in terms of the McGhee-von Hippel model of non-33 
specific protein binding to a surface19, which considers that the association for nucleic acid (NA), 34 
KNA, is modified by a cooperativity coefficient, ω, based on the protein-protein association 35 
constant. An ω value of 1 indicates no cooperativity; an ω value greater than 1000 results in 36 
steep cooperativity and reactions that appear to be two-state. Cowpea chlorotic mottle virus, 37 
which does not assemble under RNA-binding conditions, binds RNA with low cooperativity, 38 
displaying gradual assembly and partial capsids20. HBV, where the reciprocal of the pseudo-39 
critical concentration is ~105 (equivalent to ω) under physiological conditions, binds RNA 40 
tenaciously and with high cooperativity, resulting in quantitative assembly under mild 41 
conditions21. A nucleic acid scaffold can thus concentrate the capsid protein and provide 42 
additional association energy. 43 
 44 
Assembly and nucleic acids as allosteric effectors 45 
Simple theoretical models fail to describe experimental results where induced conformational 46 
changes activate assembly. This behavior fits the definition of allostery. Nucleic acid-regulated 47 
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allostery is observed with bacteriophage MS2 and retroviruses, e.g. human immunodeficiency 1 
virus (HIV) and Rous sarcoma virus (RSV).  2 
Retroviral Gag, the ‘capsid protein’ of immature retroviruses, is a multidomain protein. The 3 
elements of Gag that are most important for this discussion are the two-domain capsid (CA) 4 
segment (the primary mediator of Gag-Gag interactions), a spacer peptide that follows CA, and 5 
the RNA-binding nucleocapsid (NC) segment. The earliest suggestion of allostery in retrovirus 6 
assembly came from in vitro assembly studies using DNA oligomers and Gag22, 23. Gag 7 
dimerization was critical for assembly -- HIV Gag would not assemble with very short oligos nor 8 
if the oligo had high affinity sequences separated by a low affinity sequence, suggesting that 9 
protein-protein interaction was required to activate assembly24. Replacing NC with a leucine 10 
zipper promoted dimerization of Gag and was sufficient to drive assembly in cells25, though  11 
other factors were required in vitro26. What transitions are driven by protein oligomerization and 12 
DNA-binding?  Small angle neutron scattering (SANS) indicated that HIV Gag had a propensity 13 
to fold on itself17, thus, straightening might be a critical assembly transition. NMR studies have 14 
indicated that the spacer sequence C-terminal to Gag (in HIV and RSV) can refold27, 28. This 15 
refolding transition, driven by binding nucleic acid, might expose surfaces on CA to allow 16 
interaction28 and generate a new, potentially helix-rich interaction between the spacer 17 
peptides29, 30. Recent tomographic studies of immature HIV demonstrate CA-CA interactions 18 
and spacer peptide-spacer peptide interactions30, 31. Thus, it appears that Gag undergoes one or 19 
more conformational transitions to assemble into an immature lattice. These conformational 20 
transitions are involved in Gag assembly and are consistent with a regulatory effect, i.e. they 21 
prevent assembly by obstructing interactions28 and this obstruction can be removed by binding a 22 
co-factor26.  23 
In the RNA bacteriophage MS2, the role of allostery mediated by nucleic acid is unambiguous 24 
(Figure 2). These phages are organized with T=3 quasi-symmetry; their capsids are comprised 25 
of 90 chemically identical dimers that fit into AB and CC environments32. B half-dimers cluster 26 
around icosahedral fivefold vertices, A and C half-dimers alternate around icosahedral 27 
threefolds (quasi-sixfolds).  The A and C half-dimers are very similar, while a loop on the B 28 
subunits has a different conformation, suggesting a structural switch. Uhlenbeck and co-workers 29 
showed that a specific RNA stem-loop from the genome, TR, was necessary and by itself 30 
sufficient to induce capsid assembly33, 34. By NMR, TR-free dimer was shown to be symmetrical 31 
in solution, suggestive of a CC dimer, but TR-bound dimer was asymmetric35. Pure RNA-free 32 
dimers or pure TR-saturated dimers do not assemble rapidly, i.e. they appeared kinetically 33 
trapped35. Addition of the other form of coat protein to trapped species resulted in rapid 34 
assembly36. These results showed that both forms of dimer, symmetric and RNA-bound 35 
asymmetric, are needed for efficient assembly and that RNA was an allosteric effector.  Non-TR 36 
RNA stem-loops also trigger these effects, although they are much weaker binders, implying 37 
that multiple RNA-coat protein interactions within the capsids also contribute to conformer 38 
switching36, 37. Normal mode analysis has suggested that the RNA-induced conformational 39 
change might be one of dynamics, rather than static dimer conformations38, and is consistent 40 
with the lack of sequence-specificity. Analyzing mixed assembly reactions by mass 41 
spectrometry has provided a clear example of assembly by one dimer at a time rather than via 42 
coalescence of oligomers35. Examination of assembly reactions with TR incorporated into a 43 
longer RNA have lead to the surprising conclusion that assembly might be directed by an RNA 44 
scaffold36, funneling the system along only a few of the very many possible assembly paths36. 45 
Thus, initiation by an allosteric event and limitation by allosteric responses to protein-RNA and 46 
protein-protein interaction gives MS2 assembly the appearance of following a deterministic path. 47 
Interestingly, recent theoretical studies suggest that only a relatively small number of 48 
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intermediates will ever be used during assembly as a consequence of kinetic availability and 1 
thermodynamic stability39.  2 
 3 
Allostery in capsid construction 4 
HBV Cp assembly is also an example of allosterically controlled assembly, even though its 5 
assembly superficially resembles association of rigid bodies. For example, HBV Cp binds 6 
cooperatively to Zn++, resulting in increased intrinsic fluorescence (indicating conformational 7 
change), and faster assembly kinetics10. Conformational differences between free Cp dimer and 8 
the same protein in the context of capsid are evident in the crystal structure of an assembly 9 
defective mutant (Figure 3b)40. Dimers from capsid are symmetrical about the dimer interface41, 10 
while free dimer is asymmetric. Comparison of the structures suggests a mechanical linkage of 11 
sub-domains connected to a central chassis; these sub-domains displace one another like so 12 
many molecular dominos, leading to movements of up to 9 Å and a conformation that is 13 
geometrically incompatible with an icosahedral structure. In comparison to the crystal structure, 14 
an NMR study under non-assembly conditions showed a symmetric dimer that was readily 15 
asymmetrized by interaction with a Cp-binding peptide42. Thus, the dimer is able to adopt 16 
multiple conformations, or families of conformations, tentatively categorized as assembly-active 17 
and assembly-inactive. 18 
 19 
Allostery and antiviral strategies based on assembly 20 
For allostery, there must be a conformational change and an allosteric effector. Synthetic HBV 21 
assembly effectors have now been identified, the heteroaryldihydropyrimidines (HAPs) and 22 
phenylpropenamides. These show promise as antiviral agents, though the identity of the natural 23 
allosteric effector still remains unknown. 24 
HAPs were discovered in a search for non-nucleoside inhibitors of HBV replication and only 25 
later shown to affect HBV production by a core protein-dependent mechanism43. In vitro 26 
experiments showed that HAPs could misdirect assembly and, more critically, HAPs strengthen 27 
dimer-dimer association and accelerate assembly kinetics, sometimes by orders of magnitude9, 28 
44. A crystal structure of a HAP-capsid complex (Figure 3a) shows that HAPs lead to a change 29 
in capsid quaternary structure (but not Cp tertiary structure), bowing out icosahedral fivefolds 30 
while flattening hexagonal arrangements of dimers41. These two effects explain the basis of 31 
assembly misdirection by destabilizing fivefolds while favoring sheets of Cp dimers9. The HAP 32 
molecule fills a hydrophobic pocket at the dimer interface, increasing buried surface area and 33 
presumably the association constant while slightly distorting the geometry of Cp-Cp 34 
interaction41.  35 
Using a series of HAPs, a strong correlation was observed between antiviral effect and the rate 36 
of capsid formation, and a negligible correlation between antiviral effect and HAP stabilization of 37 
Cp-Cp interaction44. The low concentrations of the most effective HAPs required to suppress 38 
HBV replication suggest that misdirection (which requires stoichiometric concentrations of HAP) 39 
is not central to antiviral activity9. Similarly, phenylpropenamides, which were recently shown to 40 
accelerate assembly with little capsid stabilization and no assembly misdirection45, inhibit virus 41 
production in culture to yield empty capsids46.  42 
We propose that the kinetic effects of HAPs and phenylpropenamides are the critical predictor 43 
of antiviral activity44, 45. This hypothesis leads to predictions about the nature of assembly and its 44 
allosteric activation. First, as per assembly models, a kinetic effect will be most evident in the 45 
nucleation step. Starting capsid assembly at an inappropriate time (e.g. without the viral genetic 46 
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material) is likely to be bad for the virus. Second, faster kinetics indicate that effectors decrease 1 
the energy barrier to assembly, which can be best explained by invoking an effector-induced 2 
conformational change. The graphic of the HAP site in the context of free and the capsid 3 
conformations (Figure 3c) supports this hypothesis. The key point is that only the nucleation 4 
step of an assembly reaction needs be affected to gain an overall enhancement of assembly 5 
kinetics (Figure 3d). Thus, the few effectors needed for nucleation can be leveraged to consume 6 
many copies of Cp for the production of failed virus.  7 
As a point of comparison to assembly effectors, there are molecules that inhibit other allosteric 8 
transitions in viruses, such as stabilization of picornaviruses to uncoating and inhibition of HIV 9 
maturation.  The WIN compounds (e.g. pleconaril) bind to a hydrophobic pocket in rhinoviruses 10 
and polioviruses and entropically inhibit the structural transition that enables release of the viral 11 
genome47, 48. A peptide inhibitor of HIV, ‘CAI’, inhibits the structural transitions between the N-12 
terminal and C-terminal domains of CA that are associated with maturation, possibly favoring 13 
inappropriate geometries49. CAI also blocks assembly of immature Gag. However, consideration 14 
of assembly models suggests that simply inhibiting assembly could be losing strategy as it is 15 
easily overcome by overproduction of the capsid protein(s)50.  16 
 17 
Viral glycoprotein spikes 18 
While capsid and envelope glycoproteins have different functions, they share common 19 
principles that regulate their assembly.  Viral glycoproteins, or spikes, are multimers that are 20 
assembled sequentially before becoming competent for catalyzing cell entry.  The protein-21 
protein interactions within a spike and between spikes are analogous to the interactions 22 
between AUs that drive capsid assembly.  The processing events of the spikes parallel the 23 
nucleation events that initiate capsid assembly.   Furthermore, factors such as environmental 24 
pH and peptides digested from the spikes as they are folded and refolded function as allosteric 25 
regulators and sensors during assembly.   26 
The assembly of viral glycoprotein spikes requires a coordinated, highly regulated, processive 27 
mechanism to be successful.  The alphavirus system, which is discussed below, demonstrates 28 
that even with less than a half-dozen proteins, the virus has developed an assembly mechanism 29 
that relies on cellular signals and the environment to initiate conformational or allosteric changes 30 
in the assembly process.  Stabilizing any of the discrete conformations along the spike 31 
assembly path by binding of a small molecule would have tremendous potential for disrupting 32 
the timing and compartmentalization of this complex series of reactions.   33 
 34 
Assembly of alphavirus spike complexes  35 
Alphaviruses have 80 trimeric spikes, each ~70 Å in height.  Each spike is a trimer of an E2-E1 36 
heterodimer, with the E2 protein at the top of the spike and the E1 protein lying underneath, 37 
close to the lipid membrane (Figure 4)51.  In addition to interactions within each heterodimer, 38 
there are interactions between heterodimers.  An E1 molecule from one heterodimer contacts 39 
the stalk of an adjacent E2 molecule, which is part of another heterodimer51.  Each spike 40 
interacts with the nucleocapsid core via the cytoplasmic region of E2 and the E2 and E1 41 
proteins interact uniquely with each other via their transmembrane regions51.  42 
The E2 protein binds to host-cell receptor and the E1 protein mediates fusion between the viral 43 
membrane and the host cell membrane.  The receptor binding domain in E2 is positioned above 44 
the fusion peptide of E151. One could speculate that upon receptor-binding, unzippering of the 45 
E2-E1 dimer must be initiated to ultimately expose the fusion protein to the host membrane.  46 
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What might control this association and subsequent disassociation?  Viral fusion occurs in the 1 
endosome and is pH dependent52.  pH sensors or amino acid residues that destabilize the E2-2 
E1 dimer or that stabilize the post-fusion E1 trimer conformation have been identified53. 3 
Interfering with the assembly of the E2-E1 dimer, either through stabilization or destabilization, 4 
would severely affect the allosteric regulation by the sensor residues during fusion and, as a 5 
result, cell entry would be blocked.  6 
The association of the alphavirus E2-E1 dimer is a regulated process that occurs early in 7 
assembly.  The alphavirus structural proteins are translated from a sub-genomic RNA as a 8 
single polyprotein of capsid-E3-E2-6K-E1.  The capsid protein autoproteolytically cleaves itself 9 
from the rest of the polyprotein in the cytoplasm54. The remaining structural polyprotein is 10 
targeted to the endoplasmic reticulum and cleaved to pE2 (or p62, corresponding to E3+E2), 11 
6K, and E1 proteins by cellular proteases55. In the ER, E1 undergoes several conformations 12 
(α, β, γ) each differing in the number of disulfide bond rearrangements.  pE2 associates only 13 
with the E1β intermediate.  As a pE2-E1 dimer and during trimerization, E1 continues to 14 
undergo conformational changes until a stable E1ε conformation is reached.  Late in the 15 
secretory pathway E1ε becomes metastable, possibly in response to cleavage of pE2 during 16 
virus maturation (see below)56.  17 
One could speculate that pE2 undergoes similar disulfide bond rearrangement as E1 during 18 
assembly.  Both the E1 and E2 proteins have 12 cysteine residues in their ectodomain, and 19 
both interact with resident disulfide isomerases57.  pE2 has several CXXC motifs, characteristic 20 
of disulfide isomerase substrates58.  It has been suggested that E3 might function as a disulfide 21 
isomerase during alphavirus assembly59.  In the absence of pE2, E1 is not transported to the 22 
plasma membrane; in the absence of E1, low amounts of pE2 are transported to the plasma 23 
membrane56. These results emphasize the necessity of forming a specific pE2-E1 dimer early in 24 
assembly.   25 
Recently, a translational frameshift was identified in the 6K protein coding region, producing a 26 
TF (for transframe) protein60. The synthesis of TF presents a conundrum for maintaining a 27 
balance of pE2 and E1 protein during assembly.  When the 6K protein is translated, equal 28 
amounts of pE2 and E1 are translated.  However, when TF is translated, E1 translation is 29 
abrogated, presumably drastically impacting the assembly of the pE2-E1 heterodimer.  30 
 31 
Activation of viral fusion proteins 32 
Viral glycoproteins fill many roles; the most common is mediating fusion between the viral and 33 
host membrane via the fusion protein.  The atomic structures of viral fusion proteins in the pre- 34 
and post-fusion conformations have been determined and led to their classification based on 35 
structural similarities: Class I (orthomyxo-, paramyxo-, retro-, filo-, arena-, and coronaviruses), 36 
Class II (alpha- and flaviviruses), and Class III (rhabdo-, baculo- and herpesvirus)61, 62. The 37 
three classes are trimers in their fusion-active conformation.  For most viruses, the final step of 38 
glycoprotein spike assembly is the activation of the fusion protein.  This step brings the fusion 39 
protein into a metastable state, priming it for rapid fusion with the host cell upon proper 40 
activation.   41 
The requirement of a chaperone protein and its cleavage during assembly is a property of the 42 
Class II fusion proteins.  The cleavage of E3 from pE2 occurs in the trans-Golgi63and marks the 43 
transition from an immature to mature or fusogenic alphavirus particle.  Immature and mature 44 
alphaviruses are structurally similar, but immature particles have reduced infectivity levels 45 
compared to mature particles because of the presence of E3 and/or because E1 is not in a 46 
metastable state able to facilitate fusion63.  Retaining the E3 protein until the trans-Golgi might 47 
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serve to prevent premature fusion of the assembled spikes with membranes in the host cell 1 
secretory pathway. Thus, E3 is an effector of spike activity.  At the plasma membrane the spikes 2 
are arranged in large hexagonal arrays64, creating a platform for virus budding.  Host proteins 3 
have not been identified within the alphavirus glycoprotein array, suggesting lateral interactions 4 
between the spikes are important, in contrast to vesicular stomatitis virus65, HIV66, and influenza 5 
virus67 which also bud from the plasma membrane. Though not usually described as such, pE2 6 
acts as an effector of E1 activation at two different times, as a chaperone and by releasing E3 7 
for activation. 8 
Similar to pE2, the flavivirus prM protein chaperones folding of the flavivirus E protein, and 9 
cleavage of the pr peptide is required to transition from the immature to the mature flavivirus.  In 10 
contrast to alphaviruses, immature and mature flaviviruses have radically different structures68.  11 
Class I fusion proteins do not have a distinct chaperone.  Activation of the fusion proteins occurs 12 
by cleaving the fusion protein itself.  Multiple extracellular and cellular proteases have been 13 
proposed to cleave influenza HA0 both intra- and extracellularly, and we suggest that additional 14 
proteases for other viruses will also be identified69.  The class III fusion proteins do not have a 15 
chaperone protein nor do they require a cleavage step to activate the protein into a fusion-active 16 
form.  The vesicular stomatitis virus G protein is found in three reversible conformations in a pH-17 
dependent equilibrium.  The reversible conformations are a unique property among Class III 18 
fusion proteins, suggestive of allosteric conformational changes, which also prevents premature 19 
fusion during assembly70. Thus, the classification of fusion proteins is dependent on the 20 
structure of the fusion protein as well as the regulatory mechanism for its activation.  Both 21 
processes are likely controlled through allosteric mechanisms. 22 
We suggest that most viral families rely on a series of ‘sensing’ events that control protein 23 
disulfide bond linkages, glycosylation, acylation, phosphorylation, oligomerization, and transport 24 
to the appropriate cellular membrane for viral budding.  These sensors respond to pH, redox, 25 
and lipid environment as the proteins are assembled and transported through the host secretory 26 
pathway53 to allosterically enhance assembly and ensure productive spike formation. 27 
 28 
Conclusions and future directions:  interfering with conformational change and control 29 
during viral assembly 30 
While targeting specific conformations is an attractive antiviral strategy, we further propose that 31 
one should consider the dynamic nature of virus assembly and that interfering with the 32 
environmental sensors and their targets could be equally beneficial.  Both capsid and 33 
glycoprotein assembly are carefully orchestrated events requiring activation, by known and 34 
unidentified effectors.  For example, we have learned from the HAP molecules that interfering 35 
with assembly is not equivalent to inhibiting assembly.  In addition, weak interactions between 36 
protein subunits or glycoprotein complexes minimize production of misassembled spikes.  Thus, 37 
altering the kinetics, misdirecting the intermediates, stabilizing an interaction to prevent 38 
disassembly are all viable options that disrupt a highly evolved set of reactions to achieve the 39 
same end goal:  reduced virus propagation.   40 
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Box 1. An analytical description of capsid assembly 20 
 21 
Figure I. Comparison of HBV capsid assembly with simulations of capsid assembly.  Assembly 22 
of a concentration series of HBV core protein (left) compared to assembly simulations of a 30-23 
mer model  (right), where subunits have an HBV-like geometry and the nucleus is trimeric1.  The 24 
protein concentration increases from 4 µM (red) to 10 µM (purple) in 1 µM increments. The 25 
calculation is parametrized to resemble HBV assembly. For the simulation, the bimolecular rates 26 
for nucleation (knuc) and elongation (Kelong) were 70 M-1s-1 and a diffusion-limited 105 M-1s-1, 27 
respectively; the pairwise association energy was -3.8 kcal/mol. 28 
 29 
 30 
 31 
 32 
Probably the simplest way to describe assembly of a capsid of N assembly units (AUs) is as a 33 
progressive series of intermediates100. To quantify this description, one can assume that all 34 
contacts between assembly units have the same energy, energies are additive, microscopic 35 
forward rates are identical (subject to statistical considerations), and that backward rates are the 36 
product of forward rates, dissociation constants and statistical terms. The result is a series of 37 
 14 
rate equation each with terms for assembly and disassembly of n-mer and (n+1)mer, 1 
respectively. Two equations in the series are unique: the monomer equation references all 2 
intermediates and the final equation is a dead-end with only one build-up and one build-down 3 
term. 4 
d[n-mer]/dt = kforward,n[(n-1)mer][monomer] - kforward,n+1[n-mer][monomer]  5 
                      - kbackward,n[n-mer] + kbackward,n+1[(n+1)mer] 6 
Incorporating weak interactions between AUs and a slow nucleation step to limit the initiation of 7 
assembly results in robust reactions with minimal kinetics traps where errors and (meta)stable 8 
intermediates accumulate4, 39. This model necessarily leads to sigmoidal kinetics and, at 9 
equilibrium, a pseudo-critical concentration of free AU5, 100. The resulting model recapitulates 10 
most of the features observed in vitro (Figure I). 11 
Assembly can be described in much greater detail as stochastic reactions using discrete event 12 
simulators or coarse-grained molecular dynamics4. These molecular simulations provide detail, 13 
showing conditions where association of intermediates could be an important path, where 14 
reversibility is critical5, and how subunit geometry can critically affect the size and shape of 15 
assembly products4. This statistical mechanical view of assembly leads to a view of assembly 16 
that is fundamentally similar to the thermodynamic-kinetic view of the previous paragraph4. 17 
However, the detail provides additional insights into the reactions and the behaviors that can be 18 
anticipated by biological molecules. 19 
 20 
 21 
Figure legends 22 
Figure 1. Successful assembly and kinetic traps. Assembly of a dodecahedron from 23 
pentagonal assembly units (faded colors) is more robust if regulated by nucleation. In nucleated 24 
assembly (top path), the initial association reactions are relatively slow, resulting in rare 25 
nucleation centers (brightly colored oligomer) and plenty of assembly units to allow completion 26 
of capsids.  If assembly is unregulated (lower path), many partial capsids will form and very few 27 
assembly units will remain, kinetically trapping these intermediates. Of course, this trap might 28 
resolve if stochastic dissociation of some intermediates allows others to go to completion; 29 
alternatively, partial capsids can associate incorrectly, resulting in aberrant structures. 30 
 31 
Figure 2. Structure and assembly of bacteriophage MS2.  (a) The T=3 capsid of MS2 has 60 32 
AB dimers (blue and green, respectively) and 30 CC dimers (red), so that A and C subunits 33 
alternate around the quasi-sixfold axes. Icosahedral fivefold and quasi-sixfold (icosahedral  34 
threefold) vertices are shown in this representation. (b) The CC dimers are necessarily 35 
symmetric with an extended loop (highlighted in the open triangles) connecting the F and G β 36 
strands at either end. Bound RNA, the TR stem-loop (in yellow), induces asymmetry in the AB 37 
dimers so that the FG loop of the B subunit (in the pentagon) adopts a unique conformation that 38 
allows it to pack around the fivefold vertices. (c) Pure CC dimers (red) or pure AB dimers (green 39 
and blue), with bound RNA, assemble rapidly when mixed, leading to the hypothesis that 40 
assembly proceeds in a stepwise reaction. The hexameric threefold cluster is one of the major 41 
complexes identified by mass spectrometry, suggesting a highly deterministic assembly path. 42 
This hypothesis has been strongly supported by further examination of RNA-driven assembly98. 43 
This figure was adapted from Ref. 35. 44 
 45 
 15 
Figure 3. Structure an assembly of hepatitis B virus core. (a) The HBV capsid is 1 
constructed from 120 dimers arrayed with T=4 icosahedral symmetry. One of the 60 icosahedral 2 
asymmetric units, an AB and CD dimer, are highlighted against on the 20 triangular facets that 3 
surface an icosahedron. Shown are two overlaid crystal structures of HBV (blue, PDB 2G33) 4 
and HBV with bound HAP1 assembly effector (red, PDB 2G34). More red is visible as HAPs 5 
cause the capsid to expand.  Sixty HAPs are bound with high occupancy to a pocket in the C 6 
subunits (two are shown as white squares)41. (b) Dimers from the capsid (yellow) are 7 
symmetrical and identical. Asymmetric free dimers (blue, PDB 3KXS) are presumably in an 8 
assembly-inactive conformation. (c) A free dimer is color coded to show the chassis (blue) that 9 
is identical to the dimer from capsid and the three mobile subdomains (red, green, and orange). 10 
The subdomains are connected to the chassis by flexible joints, either Gly or Pro. Movement of 11 
one subdomain will force the others to shift their positions. A HAP molecule (magenta), modeled 12 
into its binding site, coordinates mobile subdomains with the chassis, facilitating the transition to 13 
an assembly-active state40. (d) HAPs accelerate assembly, even without misdirecting the 14 
reaction. Assembly of 10 µM Cp initiated by ionic strength in the presence of 0 to 15 µM HAP19. 15 
The inset micrographs show that 2 µM HAP1 yields spherical virus-like particles very fast, 16 
whereas higher HAP concentrations yield aberrant structures that scatter much more light. 17 
 18 
Figure 4. Structure of Sindbis virus.  (a) Surface view, looking down the icosahedral 2-fold 19 
axis, of Sindbis virus at 20 Å resolution.  The triangular spikes are trimers of the E2-E1 20 
heterodimer.  (b)  Cross-section through an 11 Å resolution structure of Sindbis virus.  The 21 
glycoprotein spikes are on the surface of the virus and their transmembrane region is seen 22 
traversing the lipid bilayer (transmem. helices).  The nucleocapsid core is internal to the lipid 23 
bilayer with the RNA appearing disordered.  The capsid and glycoproteins of alphaviruses both 24 
have icosahedral symmetry and their symmetry axes are aligned.  This is in contrast to most 25 
enveloped viruses.  (c)  A surface view of the glycoprotein spikes showing the arrangement of 26 
the E2 and E1 proteins.  Four monomers of E1 have been fit into the cryo-electron microscopy 27 
density of the 9 Å resolution Sindbis map and are shown in yellow, blue, red, and green.  The 28 
yellow monomers surround the icosahedral three-fold axis while the blue, red, and green 29 
monomers surround the quasi-three-fold axis.  The density corresponding to the E1 proteins has 30 
been subtracted from the density of the entire spike.  The remaining density, which corresponds 31 
to the E2 protein, is shown in gray.  The E2 protein covers the E1 protein and makes up the top 32 
portion of the spike.  Interactions between E2-E1 heterodimers, along with those within the 33 
heterodimer, are thought to stabilize the spike complex.  (d) A model of the allosteric changes 34 
that occur during assembly of the viral glycoproteins.  The polyprotein is cleaved by cellular 35 
proteases to the individual proteins (green, E3; blue, E2; red, E1; 6K is not shown for clarity). 36 
Dimerization of pE2 and E1 to (pE2-E1) is followed by trimerization of the heterodimer, (pE2-37 
E1)3.  Last, cleavage of E3 from pE2 leaves a fusion competent trimer, (E2-E1)3. Changes in 38 
color indicate conformational changes in addition to changes in aggregation state. Panels (a), 39 
(b), and (c) were adapted from Ref.51, 99 40 
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